Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Novavax Inc (NVAX)

NASDAQ
Currency in USD
Disclaimer
3.970
+0.080(+2.06%)
Closed
After Hours
3.980+0.010(+0.252%)

NVAX Comments

DONT MISS ON OCUGEN ,SENS AND ZOM 🔥🔥🔥🔥🔥🔥🔥💪💪💪
U can safely Hold it for long. Ocugen is kind mini NOVAVAX.To add to this keep in mind that Covaxin which is made by Bharat tech can be given to Childrens also and old people and it hardly has any side effects. Covaxin is effective in UK variant and African variant and can cover almost all variants of Virus. Now to add to this If Novavax is produced in Serum Institute of India then Covaxin will be produced in even bigger platform which has far more experience than Serum institute. More over Bharat Bia tech is backed with Bill Gate's funds of Billions , which again states big to make it easy approval candidate for FDA. See GEVO for example , Green energy to produce bio fuel from crops and Bill gates quietly became biggest farm land holder in World , for what ? hehehe produce crops sell eatables and to make fuel of rest and Biden has given a big position to GEVO founder hehe Now you can connect everything behind the scene and play big on Ocugen and Gevo . Hope i explained all 🙏
Please excuse for writing mistakes hehe short time
I thought Bill Gates had bad reputation in India, due to their previous unethical vaccination history. I'm not happy to hear that his invested in OCUGEN, ****** But definitely he's working his plan, alright.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.